Explore Treatments for Myositis

Myositis refers to a group of rare autoimmune diseases that cause muscle inflammation, leading to muscle weakness and, in some cases, muscle pain. These conditions occur when the body’s immune system mistakenly attacks healthy muscle tissue. In adults, the main types of myositis include Polymyositis (PM), Dermatomyositis (DM), Necrotizing Myopathy (NM) and Sporadic Inclusion Body Myositis (sIBM). There is also a form that affects children, called Juvenile Dermatomyositis (JDM). Common signs and symptoms of myositis include muscles weakness (often in the hips, thighs, shoulders, or upper arms), muscle pain, general tiredness and fatigue, trouble climbing stairs, difficulty standing from a seated position or reaching up, difficulty swallowing or breathing, a distinctive rash (on the knuckles, face, chest, or back), and a persistent dry cough. Because myositis symptoms can vary from person to person and may overlap with other conditions, getting an accurate diagnosis and proper treatment is essential. Early treatment can help manage symptoms and slow progression.

Treatments Offered by CSI

Immunoglobulins are derived from pooled human plasma collected from thousands of carefully screened donors. The plasma is rigorously processed and purified to ensure product safety and integrity. Intravenous immunoglobulin (IVIG) contains antibodies that provide broad protection against a wide range of bacteria and viruses. It is administered intravenously and is primarily used to treat three categories of conditions: primary immunodeficiency diseases, autoimmune disorders, and certain neurological conditions. 

  • Alyglo 10% 
  • Asceniv 10% 
  • Bivigam 10% 
  • Gammagard S/D 
  • Gammagard Liquid 10%
  • Gammaked 10% 
  • Gamunex-C 10% 
  • Gammaplex 5% 
  • Gammaplex 10% 
  • Octagam 5% 
  • Octagam 10% 
  • Panzyga 10% 
  • Privigen 10% 
  • Yimmugo 10% 

Immunoglobulins are derived from pooled human plasma collected from thousands of carefully screened donors. The plasma undergoes rigorous processing and purification to ensure the highest standards of safety and product integrity. Subcutaneous immunoglobulin (SCIG) contains antibodies that offer broad protection against a wide range of bacteria and viruses. It is administered under the skin (subcutaneously) and is primarily used to treat primary immunodeficiency diseases and chronic inflammatory demyelinating polyneuropathy (CIDP). SCIG is also being studied in clinical trials for use in additional conditions. 

  • Cutaquig 16.5%  
  • Cuvitru 20% 
  • Gammagard Liquid 10% 
  • Gammaked 10% 
  • Gamunex-C 10% 
  • Hizentra 20% 
  • HyQvia 10% (facilitated SCIG)  
  • Xembify 20%